Because increased copy number and expression of CKS1B has been linked to cisplatin resistance (20, 23, 29, 30), we hypothesized that the anti-miR induction would promote resistance to cisplatin in breast cancer cells. This evidence concerns the gene CKS1B and breast carcinoma.